Chloroprocaine for Inguinal Herniorrhaphy

• Status: Completed
• Trial end date: 2018-12-04
• Target enrollment: 0
• Participant gender: All

Summary

This study is to determine the minimum effective dose for intrathecal chloroprocaine in inguinal herniorrhaphy in outpatients using a Combined Spinal Epidural (CSE) anesthesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Ghent
• Treatments: Chloroprocaine; Procaine

Criteria

Inclusion Criteria:

• Outpatients for unilateral inguinal hernia repair

• ASA I - II - III

Exclusion Criteria:

• hypersensitivity to amino-ester local anesthetics, para-aminobenzoic acid or sufentanil

• contraindications to spinal or epidural anesthesia

• bilateral inguinal herniorrhaphy

• extremes of height and weight (BMI 20 or 35 kg/m2, height 150 cm or 185 cm)